ImpediMed Limited (ASX:IPD)
Australia · Delayed Price · Currency is AUD 0.0060
0.00 (0.00%)
Aug 7, 2026, 4:10 PM AEST
ImpediMed Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 14.23 | 12.72 | 10.32 | 11.34 | 10.57 | 8.41 |
Revenue Growth | 11.85% | 23.31% | -9.04% | 7.36% | 25.65% | 46.47% |
Gross Profit Gross Profit Growth | 12.26 | 10.98 | 9.01 | 9.8 | 8.86 | 6.86 |
Operating Income Operating Income Growth | -22.29 | -23.01 | -23.07 | -22.87 | -21.47 | -22.97 |
Net Income Net Income Growth | -24.37 | -23.24 | -19.79 | -20.52 | -19.87 | -20.71 |
Earnings Per Share EPS Growth | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
North America North America Growth | 12.68 | 11.48 | 9.28 | 8.26 | 6.1 | 5.25 |
Australia/Rest of World (ROW) Australia/Rest of World (ROW) Growth | 1.46 | 1.16 | 0.89 | 1.05 | 1.13 | 1.3 |
Unallocated Unallocated Growth | - | 0.09 | 0.15 | 2.04 | 3.34 | 1.86 |
Total Total Growth | 14.23 | 12.72 | 10.32 | 11.34 | 10.57 | 8.41 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 18.85 | 22.18 | 24.63 | 45.71 | 40.73 | 19.68 |
Total Debt Total Debt Growth | 21.55 | 14.49 | 1.14 | 1.45 | 0.17 | 0.47 |
Net Cash (Debt) Net Cash Growth | -2.71 | 7.69 | 23.49 | 44.26 | 40.56 | 19.21 |
Net Cash Growth | - | -67.25% | -46.93% | 9.13% | 111.17% | 2.21% |
Net Cash Per Share Net Cash Per Share Growth | -0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.02 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -15.39 | -14.65 | -17.79 | -18.05 | -15.66 | -13.26 |
Capital Expenditures CapEx Growth | -0.06 | -0.06 | -0.08 | -0.39 | -0.06 | -0.07 |
Free Cash Flow Free Cash Flow Growth | -15.45 | -14.71 | -17.87 | -18.44 | -15.72 | -13.32 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 86.14% | 86.25% | 87.27% | 86.37% | 83.83% | 81.54% |
Operating Margin | -156.65% | -180.82% | -223.57% | -201.56% | -203.16% | -273.12% |
Pretax Margin | -171.05% | -182.42% | -191.46% | -180.62% | -187.66% | -245.77% |
Profit Margin | -171.25% | -182.62% | -191.78% | -180.90% | -188.09% | -246.24% |
FCF Margin | -108.54% | -115.57% | -173.18% | -162.56% | -148.82% | -158.45% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 8, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PS Ratio | 1.54 | 5.58 | 14.12 | 34.46 | 10.27 | 18.63 |